Form 8-K - Current report:
SEC Accession No. 0001493152-24-032873
Filing Date
2024-08-16
Accepted
2024-08-16 17:15:09
Documents
13
Period of Report
2024-08-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34847
  Complete submission text file 0001493152-24-032873.txt   202754

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE arth-20240814.xsd EX-101.SCH 3039
3 XBRL LABEL FILE arth-20240814_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE arth-20240814_pre.xml EX-101.PRE 22375
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3354
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 241217596
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)